Although classified in the United States as Schedule I drugs, medical and recreational cannabis and Δ9-tetrahydrocannabinol (THC) are becoming increasingly consumed by pregnant women. Determining the potential adverse effects following exposure during early development is essential for risk communication.
Materials and Methods:
Following exposure to 0.08, 0.4, or 1 µM THC for 6–96 h post fertilization (hpf) in wild-type zebrafish, latent behavioral effects caused by THC were evaluated at 3 weeks post fertilization (wpf) (juvenile), 11 wpf (onset of sexual maturity), and 24 wpf (adult) and in F1 offspring. Bioenergetics were measured in F0 adult brain mitochondria.
Results:
Open field tests conducted at 3 wpf and 11 wpf indicated concentration-dependent hyperactivity (increased velocity) and increased thigmotaxis (anxiety-like wall-hugging) at the two highest THC concentrations. The 5D F1 generation of zebrafish (exposed to THC as germ cells) also demonstrated significant dark-phase hyperactivity at 120 hpf in the larval photomotor response. Brain mitochondrial bioenergetics in adults developmentally exposed to THC showed that oxygen consumption rate was significantly increased at the two highest THC concentrations for females and the highest concentration for males.
Discussion:
Collectively, these results show that exposure to THC during a critical period of development caused behavioral and mitochondrial alterations that persisted into adulthood and across generations.
Tirado-MuñozJ, Lopez-RodriguezAB, FonsecaF, et al.Effects of cannabis exposure in the prenatal and adolescent periods: Preclinical and clinical studies in both sexes. Front Neuroendocrinol, 2020; 57:100841; doi: 10.1016/j.yfrne.2020.100841
2.
NashedMG, HardyDB, LavioletteSR. Prenatal cannabinoid exposure: Emerging evidence of physiological and neuropsychiatric abnormalities. Front Psychiatry, 2020; 11:624275.
3.
MetzTD, StickrathEH. Marijuana use in pregnancy and lactation: A review of the evidence. Am J Obstet Gynecol, 2015; 213(6):761–778; doi: 10.1016/j.ajog.2015.05.025
4.
ChandraS, RadwanMM, MajumdarCG, et al.New trends in cannabis potency in USA and Europe during the last decade (2008–2017). Eur Arch Psychiatry Clin Neurosci, 2019; 269(1):5–15; doi: 10.1007/s00406-019-00983-5
5.
HowardDS, DhanrajDN, DevaiahCG, et al.Cannabis use based on urine drug screens in pregnancy and its association with infant birth weight. J Addict Med, 2019; 13(6):436–441.
6.
VolkowND, HanB, ComptonWM, et al.Self-reported medical and nonmedical cannabis use among pregnant women in the United States. JAMA, 2019; 322(2):167–169.
7.
El MarrounH, TiemeierH, SteegersEAP, et al.Intrauterine cannabis exposure affects fetal growth trajectories: The Generation R Study. J Am Acad Child Adolesc Psychiatry, 2009; 48(12):1173–1181.
8.
GunnJKL, RosalesCB, CenterKE, et al.Prenatal exposure to cannabis and maternal and child health outcomes: A systematic review and meta-analysis. BMJ Open, 2016; 6(4):e009986; doi: 10.1136/bmjopen-2015-009986
9.
National Academies of Sciences E and M. The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. National Academies Press: Washington, DC; 2017. Available from: https://www.nap.edu/catalog/23476
10.
MetzTD, AllshouseAA, HogueCJ, et al.Maternal marijuana use, adverse pregnancy outcomes, and neonatal morbidity. Am J Obstet Gynecol, 2017; 217(4):478.e1–478.e8; doi: 10.1016/j.ajog.2017.05.050
11.
MarchandG, MasoudAT, GovindanM, et al.Birth outcomes of neonates exposed to marijuana in utero: A systematic review and meta-analysis. JAMA Netw Open, 2022; 5(1):E2145653.
12.
PaulSE, HatoumAS, FineJD, et al.Associations between prenatal cannabis exposure and childhood outcomes: Results from the ABCD Study. JAMA Psychiatry, 2021; 78(1):64–76.
13.
BarangerDAA, PaulSE, ColbertSMC, et al.Association of mental health burden with prenatal cannabis exposure from childhood to early adolescence. JAMA Pediatr, 2022; 176(12):1261–1263.
14.
SinghS, FilionKB, AbenhaimHA, et al.Prevalence and outcomes of prenatal recreational cannabis use in high-income countries: A scoping review. BJOG, 2020; 127(1):8–16.
15.
RubinoT, ParolaroD. Sexually dimorphic effects of cannabinoid compounds on emotion and cognition. Front Behav Neurosci, 2011; 5:64–65.
16.
WileyJ. Sex-dependent effects of Δ9-tetrahydrocannabinol on locomotor activity in mice. Neurosci Lett, 2003; 352(2):77–80.
17.
El MarrounH, HudziakJJ, TiemeierH, et al.Intrauterine cannabis exposure leads to more aggressive behavior and attention problems in 18-month-old girls. Drug Alcohol Depend, 2011; 118(2–3):470–474; doi: 10.1016/j.drugalcdep.2011.03.004
18.
HalladayJE, BoyleMH, MunnC, et al.Sex differences in the association between cannabis use and suicidal ideation and attempts, depression, and psychological distress among Canadians. Can J Psychiatry, 2019; 64(5):345–350.
19.
CraneNA, SchusterRM, Fusar-PoliP, et al.Effects of cannabis on neurocognitive functioning: Recent advances, neurodevelopmental influences, and sex differences. Neuropsychol Rev, 2013; 23(2):117–137.
20.
CalakosKC, BhattS, FosterDW, et al.Mechanisms underlying sex differences in cannabis use. Curr Addict Rep, 2017; 4(4):439–453.
21.
SoudersCL, LiangX, WangX, et al.High-throughput assessment of oxidative respiration in fish embryos: Advancing adverse outcome pathways for mitochondrial dysfunction. Aquat Toxicol, 2018; 199:162–173; doi: 10.1016/j.aquatox.2018.03.031
22.
LeawB, NairS, LimR, et al.Mitochondria, bioenergetics and excitotoxicity: New therapeutic targets in perinatal brain injury. Front Cell Neurosci, 2017; 11:199.
23.
CaoF, SoudersCL, LiP, et al.Developmental neurotoxicity of maneb: Notochord defects, mitochondrial dysfunction and hypoactivity in zebrafish (Danio rerio) embryos and larvae. Ecotoxicol Environ Saf, 2019; 170:227–237; doi: 10.1016/j.ecoenv.2018.11.110
24.
PinhoBR, SantosMM, Fonseca-SilvaA, et al.How mitochondrial dysfunction affects zebrafish development and cardiovascular function: An in vivo model for testing mitochondria-targeted drugs. Br J Pharmacol, 2013; 169(5):1072–1090.
25.
Busquets-GarciaA, DesprezT, Metna-LaurentM, et al.Dissecting the cannabinergic control of behavior: The where matters. Bioessays, 2015; 37(11):1215–1225.
26.
LipinaC, IrvingAJ, HundalHS. Mitochondria: A possible nexus for the regulation of energy homeostasis by the endocannabinoid system? Am J Physiol - Endocrinol Metab, 2014; 307(1).
27.
FišarZ, SinghN, HroudováJ. Cannabinoid-induced changes in respiration of brain mitochondria. Toxicol Lett, 2014; 231(1):62–71.
28.
TruongL, ReifDM, MaryLS, et al.Multidimensional in vivo hazard assessment using zebrafish. Toxicol Sci, 2014; 137(1):212–233.
29.
BruniG, LakhaniP, KokelD. Discovering novel neuroactive drugs through high-throughput behavior-based chemical screening in the zebrafish. Front Pharmacol, 2014; 5(July):153.
30.
SufianMS, AminMR, KanyoR, et al.CB1 and CB2 receptors play differential roles in early zebrafish locomotor development. J Exp Biol, 2019; 222(Pt 16):jeb206680.
31.
LuchtenburgFJ, SchaafMJMM, RichardsonMK. Functional characterization of the cannabinoid receptors 1 and 2 in zebrafish larvae using behavioral analysis. Psychopharmacology (Berl), 2019; 236(7):2049–2058.
32.
KalueffAV, StewartAM, GerlaiR. Zebrafish as an emerging model for studying complex brain disorders. Trends Pharmacol Sci, 2014; 35(2):63–75.
33.
StewartAM, BraubachO, SpitsbergenJ, et al.Zebrafish models for translational neuroscience research: From tank to bedside. Trends Neurosci, 2014; 37(5):264–278.
34.
WangXH, SoudersCL, ZhaoYH, et al.Paraquat affects mitochondrial bioenergetics, dopamine system expression, and locomotor activity in zebrafish (Danio rerio). Chemosphere, 2018; 191:106–117; doi: 10.1016/j.chemosphere.2017.10.032
35.
WangXH, SoudersCL, ZhaoYH, et al.Mitochondrial bioenergetics and locomotor activity are altered in zebrafish (Danio rerio) after exposure to the bipyridylium herbicide diquat. Toxicol Lett, 2018; 283:13–20; doi: 10.1016/j.toxlet.2017.10.022
36.
ZhangJL, Laurence SoudersC, DenslowND, et al.Quercetin, a natural product supplement, impairs mitochondrial bioenergetics and locomotor behavior in larval zebrafish (Danio rerio). Toxicol Appl Pharmacol, 2017; 327:30–38; doi: 10.1016/j.taap.2017.04.024
37.
CartyDR, ThorntonC, GledhillJH, et al.Developmental effects of cannabidiol and Δ9-tetrahydrocannabinol in zebrafish. Toxicol Sci, 2018; 162(1):137–145.
38.
PandelidesZ, AluruN, ThorntonC, et al.Transcriptomic changes and the roles of cannabinoid receptors and PPARγ in developmental toxicities following exposure to Δ9-tetrahydrocannabinol and cannabidiol. Toxicol Sci, 2021; 182(1):44–59.
39.
NixonJ, AbramoviciH, CabecinhaA, et al.Assessing the bioactivity of cannabis extracts in larval zebrafish. J Cannabis Res, 2021; 3(1):44; doi: 10.1186/s42238-021-00103-y
40.
SamarutÉ, NixonJ, KundapUP, et al.Single and synergistic effects of cannabidiol and δ-9-tetrahydrocannabinol on zebrafish models of neuro-hyperactivity. Front Pharmacol, 2019; 10:226.
41.
AhmedKT, AminMR, ShahP, et al.Motor neuron development in zebrafish is altered by brief (5-hr) exposures to THC (Δ9-tetrahydrocannabinol) or CBD (cannabidiol) during gastrulation. Sci Rep, 2018; 8(1):10518.
42.
FerreiraIL, CarmoC, NaiaL, et al.Assessing mitochondrial function in in vitro and ex vivo models of huntington’s disease. In: Huntington’s Disease, Methods in Molecular Biology. Springer; 2018. p. 415–42. Available from: http://link.springer.com/10.1007/978-1-4939-7825-0_19.
43.
AminMR, KharaL, SzaszkiewiczJ, et al.Brief exposure to (-) THC affects zebrafish embryonic locomotion with effects that persist into the next generation. Sci Rep, 2025; 15(1):2203.
44.
Acevedo-CanabalA, Colón-CruzL, Rodriguez-MoralesR, et al.Altered swimming behaviors in zebrafish larvae lacking cannabinoid receptor 2. Cannabis Cannabinoid Res, 2019; 4(2):88–101.
45.
PinheiroEF, CardosoPB, LuzWL, et al.Putative activation of cannabinoid receptor type 1 prevents brain oxidative stress and inhibits aggressive-like behavior in zebrafish. Cannabis Cannabinoid Res, 2024; 9(1):65–73.
46.
FriedPA. Marihuana use by pregnant women: Neurobehavioral effects in neonates. Drug Alcohol Depend, 1980; 6(6):415–424.
47.
GoldschmidtL, DayNL, RichardsonGA. Effects of prenatal marijuana exposure on child behavior problems at age 10. Neurotoxicol Teratol, 2000; 22(3):325–336.
48.
DayNL, LeechSL, GoldschmidtL. The effects of prenatal marijuana exposure on delinquent behaviors are mediated by measures of neurocognitive functioning. Neurotoxicol Teratol, 2011; 33(1):129–136.
49.
GrayKA, DayNL, LeechS, et al.Prenatal marijuana exposure: Effect on child depressive symptoms at ten years of age. Neurotoxicol Teratol, 2005; 27(3):439–448.
50.
McLemoreGL, RichardsonKA. Data from three prospective longitudinal human cohorts of prenatal marijuana exposure and offspring outcomes from the fetal period through young adulthood. Data Brief, 2016; 9:753–757; doi: 10.1016/j.dib.2016.10.005
51.
SmithAM, FriedPA, HoganMJ, et al.Effects of prenatal marijuana on response inhibition: An fMRI study of young adults. Neurotoxicol Teratol, 2004; 26(4):533–542.
VanRyzinJW, MarquardtAE, ArgueKJ, et al.Microglial phagocytosis of newborn cells is induced by endocannabinoids and sculpts sex differences in juvenile rat social play. Neuron, 2019; 102(2):435–449.e6; doi: 10.1016/j.neuron.2019.02.006
54.
BaraA, FerlandJMN, RompalaG, et al.Cannabis and synaptic reprogramming of the developing brain. Nat Rev Neurosci, 2021; 22(7):423–438.
55.
KumariS, BartonGP, GossKN. Increased mitochondrial oxygen consumption in adult survivors of preterm birth. Pediatr Res, 2021; 90(6):1147–1152.
56.
GyllenhammerLE, PicardM, McGillMA, et al.Prospective association between maternal allostatic load during pregnancy and child mitochondrial content and bioenergetic capacity. Psychoneuroendocrinology, 2022; 144(July):105868; doi: 10.1016/j.psyneuen.2022.105868
57.
HowZT, Gamal El-DinM. A critical review on the detection, occurrence, fate, toxicity, and removal of cannabinoids in the water system and the environment. Environ Pollut, 2021; 268(Pt A):115642; doi: 10.1016/j.envpol.2020.115642
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
